WS #8592

The dominant signal in this window is the escalating military confrontation in the Middle East. Iran's Khatam al-Anbiya Headquarters warned that military ships intervening in Strait of Hormuz management will become targets, while U.S. forces disabled a non-compliant vessel in the Gulf of Oman to prevent blockade violation. This follows reports of U.S. strikes on Iranian military sites and Iran's retaliation against a U.S. base in Kuwait, with rumors of a 60-day ceasefire deal. The situation is escalating, with Polymarket showing active trading on Iran-related outcomes. Separately, BioNTech and Bristol Myers Squibb released encouraging Phase 2 data for pumitamig in non-small cell lung cancer, showing high response rates. The Freedom 250 concert continues to see mass cancellations, but this is noise. The Champions League final between PSG and Arsenal went to extra time after a 1-1 draw, but this is non-market. The previous synthesis's Incyte lymphoma therapy data and Ukraine drone strikes remain valid but have no new data in this window.